Safety of chidamide plus rituximab in elderly patients with relapsed or refractory B-cell lymphoma in China: a multicenter, single-arm, phase II study

Annals of Translational Medicine ◽

10.21037/atm-21-6019 ◽

2021 ◽

Vol 0 (0) ◽

pp. 0-0

Author(s):

Xinrui Chen ◽

Huaqing Wang ◽

Xiuhua Sun ◽

Liping Su ◽

Fengting Liu ◽

...

Keyword(s):

Elderly Patients ◽

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma

Download Full-text

Clinical Efficacy and Epigenetic Biomarkers in a Phase II Study of Chidamide Plus R-CHOP in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

SSRN Electronic Journal ◽

10.2139/ssrn.3532538 ◽

2020 ◽

Author(s):

Mu-Chen Zhang ◽

Peng-Peng Xu ◽

Ying Fang ◽

Li Wang ◽

Shu Cheng ◽

...

Keyword(s):

Elderly Patients ◽

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Newly Diagnosed ◽

Epigenetic Biomarkers ◽

Large B Cell Lymphoma ◽

Download Full-text

Phase II Study of Bendamustine and Ofatumumab in Elderly Patients with Newly Diagnosed Diffuse Large B‐Cell Lymphoma Who Are Poor Candidates for R‐CHOP Chemotherapy

The Oncologist ◽

10.1634/theoncologist.2019-0286 ◽

2019 ◽

Vol 24 (8) ◽

pp. 1035 ◽

Author(s):

Ian W. Flinn ◽

Jack Erter ◽

Davey B. Daniel ◽

Joseph R. Mace ◽

Jesus G. Berdeja

Keyword(s):

Elderly Patients ◽

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Newly Diagnosed ◽

Chop Chemotherapy ◽

Large B Cell Lymphoma ◽

Download Full-text

PS1068 SAFETY ANALYSIS OF AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP NHL29: A PHASE II STUDY OF IBRUTINIB, RITUXIMAB AND MINI-CHOP IN VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B CELL LYMPHOMA

10.1097/01.hs9.0000562568.25368.82 ◽

2019 ◽

Vol 3 (S1) ◽

pp. 483-484

Author(s):

E. Verner ◽

A. Johnston ◽

N. Pati ◽

E. Hawkes ◽

H.P. Lee ◽

...

Keyword(s):

Elderly Patients ◽

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Newly Diagnosed ◽

Very Elderly ◽

Large B Cell Lymphoma ◽

Download Full-text

A phase II study of R-COMP14 in elderly patients with high-risk diffuse large B-cell lymphoma (DLBCL) and moderate to high “life threat” impact cardiopathy.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.8058 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 8058-8058

Author(s):

G. Corazzelli ◽

F. Frigeri ◽

M. Arcamone ◽

A. Lucania ◽

G. Capobianco ◽

...

Keyword(s):

High Risk ◽

Elderly Patients ◽

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Life Threat ◽

Download Full-text

A multicenter, phase II study of R-THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, indolent B-cell lymphoma

Journal of Clinical and Experimental Hematopathology ◽

10.3960/jslrt.21004 ◽

2021 ◽

Author(s):

Kazunori Ohnishi ◽

Ken Ohmachi ◽

Kiyoshi Ando ◽

Kazuhito Yamamoto ◽

Tatsuya Ito ◽

...

Keyword(s):

Elderly Patients ◽

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Advanced Stage ◽

Newly Diagnosed ◽

Multicenter Phase

Download Full-text

Phase II study of the CPT-11, mitoxantrone and dexamethasone regimen in combination with rituximab in elderly patients with relapsed diffuse large B-cell lymphoma

Cancer Science ◽

10.1111/j.1349-7006.2006.00249.x ◽

2006 ◽

Vol 97 (9) ◽

pp. 933-937 ◽

Author(s):

Nozomi Niitsu ◽

Mika Kohuri ◽

Masaaki Higashihara ◽

Masami Bessho

Keyword(s):

Elderly Patients ◽

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Download Full-text

A phase II study of a THP-COP regimen for the treatment of elderly patients aged 70 years or older with diffuse large B-cell lymphoma

Hematological Oncology ◽

10.1002/hon.815 ◽

2007 ◽

Vol 25 (3) ◽

pp. 107-114 ◽

Author(s):

Hisashi Tsurumi ◽

Takeshi Hara ◽

Naoe Goto ◽

Nobuhiro Kanemura ◽

Senji Kasahara ◽

...

Keyword(s):

Elderly Patients ◽

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Download Full-text

Faculty Opinions recommendation of Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717958945.793462993 ◽

2012 ◽

Author(s):

Nicolas Mounier

Keyword(s):

B Cell ◽

Phase Ii ◽

Lymphoid Tissue ◽

Marginal Zone ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Medikamentöse Tumortherapie

Download Full-text

LONG‐TERM ANALYSES FROM L‐MIND, A PHASE II STUDY OF TAFASITAMAB PLUS LENALIDOMIDE (LEN) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (R/R DLBCL)

Hematological Oncology ◽

10.1002/hon.28_2879 ◽

2021 ◽

Vol 39 (S2) ◽

Author(s):

J Duell ◽

K. J Maddocks ◽

E González‐Barca ◽

W Jurczak ◽

A. M Liberati ◽

...

Keyword(s):

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Download Full-text

A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma)

Haematologica ◽

10.3324/haematol.2012.065995 ◽

2012 ◽

Vol 98 (3) ◽

pp. 353-356 ◽

Author(s):

B. Kiesewetter ◽

M. Troch ◽

W. Dolak ◽

L. Mullauer ◽

J. Lukas ◽

...

Keyword(s):

B Cell ◽

Phase Ii ◽

Malt Lymphoma ◽

Lymphoid Tissue ◽

Marginal Zone ◽

Phase Ii Study ◽

Cell Lymphoma ◽

B Cell Lymphoma

Download Full-text